Linde plc (FRA:LIN)

Marinus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,786	4,850	4,664	5,436	2,823	3,754
Cash & Short-Term Investments	4,786	4,850	4,664	5,436	2,823	3,754
Cash Growth	3.46%	3.99%	-14.20%	92.56%	-24.80%	39.04%
Accounts Receivable	5,353	4,737	4,760	4,683	4,633	4,329
Other Receivables	137	325	332	225	196	261
Receivables	5,490	5,062	5,092	4,908	4,829	4,590
Inventory	2,122	1,946	2,115	1,978	1,733	1,729
Prepaid Expenses	1,079	358	410	433	405	401
Other Current Assets	150	729	339	292	369	450
Total Current Assets	13,627	12,945	12,620	13,047	10,159	10,924
Property, Plant & Equipment	26,928	25,764	25,490	24,420	27,019	29,801
Long-Term Investments	-	2,236	2,377	2,534	2,637	2,084
Goodwill	27,812	25,937	26,751	25,817	27,038	28,201
Other Intangible Assets	12,082	11,330	12,399	12,420	13,802	16,184
Long-Term Deferred Tax Assets	-	428	226	230	242	268
Long-Term Deferred Charges	-	58	60	66	62	96
Other Long-Term Assets	5,583	1,449	888	1,124	646	671
Total Assets	86,078	80,147	80,811	79,658	81,605	88,229
Accounts Payable	2,593	2,507	3,020	2,995	3,503	3,095
Accrued Expenses	-	2,479	2,606	2,594	2,412	2,422
Short-Term Debt	4,879	4,223	4,713	4,117	1,163	3,251
Current Portion of Long-Term Debt	1,340	2,057	1,263	1,599	1,709	751
Current Portion of Leases	-	230	227	223	262	275
Current Income Taxes Payable	-	637	664	613	429	542
Current Unearned Revenue	1,261	1,194	1,901	3,073	2,940	1,769
Other Current Liabilities	4,641	1,217	1,323	1,265	1,225	1,635
Total Current Liabilities	14,714	14,544	15,717	16,479	13,643	13,740
Long-Term Debt	19,701	15,343	13,397	12,198	11,335	12,152
Long-Term Leases	-	756	715	654	747	794
Long-Term Unearned Revenue	1,233	1,098	1,049	913	-	532
Long-Term Deferred Tax Liabilities	-	5,659	5,749	5,886	6,239	6,704
Other Long-Term Liabilities	10,444	2,740	2,396	1,501	2,398	1,762
Total Liabilities	46,092	40,659	39,716	38,271	36,164	38,647
Common Stock	1	1	1	1	1	1
Additional Paid-In Capital	39,411	39,603	39,812	40,005	40,180	40,202
Retained Earnings	14,595	12,634	8,845	20,541	18,710	17,178
Treasury Stock	-9,242	-7,252	-3,133	-14,737	-9,808	-5,374
Comprehensive Income & Other	-6,250	-6,894	-5,805	-5,782	-5,048	-4,690
Total Common Equity	38,515	38,092	39,720	40,028	44,035	47,317
Minority Interest	1,471	1,396	1,375	1,359	1,406	2,265
Shareholders' Equity	39,986	39,488	41,095	41,387	45,441	49,582
Total Liabilities & Equity	86,078	80,147	80,811	79,658	81,605	88,229
Total Debt	25,920	22,609	20,315	18,791	15,216	17,223
Net Cash (Debt)	-21,134	-17,759	-15,651	-13,355	-12,393	-13,469
Net Cash Per Share	-44.28	-36.84	-31.79	-26.50	-23.75	-25.36
Filing Date Shares Outstanding	468.91	472.91	481.58	492.16	507.74	522.84
Total Common Shares Outstanding	468.91	473.24	482.45	492.46	508.68	523.29
Working Capital	-1,087	-1,599	-3,097	-3,432	-3,484	-2,816
Book Value Per Share	82.14	80.49	82.33	81.28	86.57	90.42
Tangible Book Value	-1,379	825	570	1,791	3,195	2,932
Tangible Book Value Per Share	-2.94	1.74	1.18	3.64	6.28	5.60
Land	-	1,045	1,087	1,047	1,121	1,259
Buildings	-	3,355	3,275	3,002	3,265	3,327
Machinery	-	39,574	37,121	33,988	32,093	31,204
Construction In Progress	-	4,086	3,404	3,239	3,062	3,257
Order Backlog	-	7,100	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.